A Study of BL-M07D1 vs Pembrolizumab-platinum Chemotherapy in First-line Treatment of HER2-mutant Advanced or Metastatic Non-squamous NSCLC
Abroad (travel likely)RecruitingPHASE3
Conditions
Non-squamous Non-small Cell Lung Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Contact: Study coordinator (Li Zhang)